Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-100250

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 16, 2016M1,548$0.00A94,646D
Common StockF1Feb 16, 2016M817$0.00A95,463D
Common StockFeb 17, 2016S1,183$16.30D94,280D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Feb 16, 2016M1,548D——Common Stock1,54812,388D
Restricted Stock UnitsF3,F6,F7—Feb 16, 2016M817D——Common Stock8177,083D

Explanation of responses